BISAGLIA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 6.656
AS - Asia 3.560
EU - Europa 1.547
AF - Africa 608
SA - Sud America 605
OC - Oceania 62
Continente sconosciuto - Info sul continente non disponibili 30
Totale 13.068
Nazione #
US - Stati Uniti d'America 6.327
SG - Singapore 1.188
CN - Cina 574
VN - Vietnam 503
BR - Brasile 390
IT - Italia 316
HK - Hong Kong 263
BD - Bangladesh 202
FR - Francia 146
FI - Finlandia 139
DE - Germania 135
IN - India 96
GB - Regno Unito 91
TR - Turchia 90
NL - Olanda 74
PL - Polonia 56
UA - Ucraina 52
RU - Federazione Russa 51
IQ - Iraq 50
SE - Svezia 50
CA - Canada 47
PK - Pakistan 42
AR - Argentina 40
ZA - Sudafrica 40
JP - Giappone 39
CO - Colombia 36
MX - Messico 34
AL - Albania 31
PH - Filippine 31
ES - Italia 30
MA - Marocco 29
ID - Indonesia 28
JO - Giordania 28
AE - Emirati Arabi Uniti 27
BJ - Benin 26
KG - Kirghizistan 26
EC - Ecuador 25
CI - Costa d'Avorio 24
CZ - Repubblica Ceca 24
LB - Libano 24
GR - Grecia 23
MY - Malesia 23
VE - Venezuela 23
HN - Honduras 22
PY - Paraguay 22
SA - Arabia Saudita 22
TW - Taiwan 22
EG - Egitto 21
LC - Santa Lucia 21
TH - Thailandia 21
AO - Angola 20
AU - Australia 20
IL - Israele 20
PS - Palestinian Territory 20
UZ - Uzbekistan 20
BG - Bulgaria 19
GH - Ghana 19
GT - Guatemala 19
MN - Mongolia 19
DZ - Algeria 18
KE - Kenya 18
MW - Malawi 18
YT - Mayotte 18
AT - Austria 17
CW - ???statistics.table.value.countryCode.CW??? 17
HR - Croazia 17
KH - Cambogia 17
SN - Senegal 17
BA - Bosnia-Erzegovina 16
BB - Barbados 16
BY - Bielorussia 16
CH - Svizzera 16
IE - Irlanda 16
JM - Giamaica 16
KR - Corea 16
ML - Mali 16
MU - Mauritius 16
PE - Perù 16
BE - Belgio 15
BF - Burkina Faso 15
CG - Congo 15
CL - Cile 15
NO - Norvegia 15
TN - Tunisia 15
AZ - Azerbaigian 14
BZ - Belize 14
CD - Congo 14
CU - Cuba 14
CV - Capo Verde 14
GF - Guiana Francese 14
IS - Islanda 14
LA - Repubblica Popolare Democratica del Laos 14
ME - Montenegro 14
MK - Macedonia 14
MR - Mauritania 14
NC - Nuova Caledonia 14
PR - Porto Rico 14
SI - Slovenia 14
SK - Slovacchia (Repubblica Slovacca) 14
UG - Uganda 14
Totale 12.451
Città #
Ashburn 866
Singapore 785
San Jose 673
Fairfield 604
Chandler 400
Woodbridge 400
Ann Arbor 359
Houston 298
Hong Kong 231
Seattle 206
Wilmington 205
Cambridge 191
Beijing 162
Ho Chi Minh City 146
Santa Clara 138
Jacksonville 122
Hanoi 121
Los Angeles 104
Boardman 97
Princeton 72
Helsinki 66
New York 65
San Diego 65
Lauterbourg 60
Council Bluffs 54
Munich 54
Padova 48
Istanbul 46
Chicago 41
Dong Ket 40
Roxbury 37
São Paulo 35
Des Moines 32
Buffalo 31
Medford 29
Bytom 28
Orem 27
Amman 26
Nanjing 26
Turku 26
Bishkek 25
Cotonou 25
Abidjan 24
London 22
Castries 21
Dallas 20
Milan 20
Tokyo 19
Haiphong 18
Rome 18
Dakar 17
Johannesburg 17
Tashkent 17
Ulan Bator 17
Warsaw 17
Nuremberg 16
Phoenix 16
Shenyang 16
Accra 15
Baghdad 15
Falls Church 15
Guangzhou 15
Luanda 15
Montreal 15
Phnom Penh 15
Baku 14
Hebei 14
Kampala 14
Melbourne 14
Nairobi 14
Noumea 14
Praia 14
Tirana 14
Bamako 13
Bridgetown 13
Chennai 13
Dili 13
Ouagadougou 13
Redondo Beach 13
Reykjavik 13
Shanghai 13
Vientiane 13
Willemstad 13
Boston 12
Charlotte 12
Dublin 12
Dushanbe 12
Havana 12
Lima 12
Lusaka 12
Nouakchott 12
Panama City 12
Amsterdam 11
Athens 11
Frankfurt am Main 11
Guatemala City 11
Guayaquil 11
Hefei 11
Lahore 11
Libreville 11
Totale 7.904
Nome #
Editorial: Critical Analyses of Mechanism-Based Therapies Against Parkinson's Disease: Concepts and Perspectives 367
Dopamine oxidation products as mitochondrial endotoxins, a potential molecular mechanism for preferential neurodegeneration in Parkinson Disease 340
Superoxide Dismutases SOD1 and SOD2 Rescue the Toxic Effect of Dopamine-Derived Products in Human SH-SY5Y Neuroblastoma Cells. 333
Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation 332
Circadian Rhythm Abnormalities in Parkinson's Disease from Humans to Flies and Back 288
DJ-1 as a deglycating enzyme: A unique function to explain a multifaceted protein? 280
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function 280
Covalent alfa-synuclein dimers: chemico-physical and aggregation properties 274
Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 andCys-53 269
Activation of the RegB Endoribonuclease by the S1 Ribosomal Protein Is Due to Cooperation between the S1 Four C-terminal Modules in a Substrate-dependant Manner 262
DJ-1 is a copper chaperone acting on SOD1 activation. 251
Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View 246
Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss. 245
Broken helix in vesicle and micelle-bound alpha-synuclein: Insights from site-directed spin labeling-EPR experiments and MD simulations 242
Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson's Disease. 239
DJ-1 promotes energy balance by regulating both mitochondrial and autophagic homeostasis 236
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease? 228
Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson’s disease therapies. 227
Anti-oxidants in Parkinson's disease therapy: a critical point of view 226
Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease. 224
Activation of RegB endoribonuclease by S1 ribosomal protein requires an 11 nt conserved sequence 224
A Topological Model of the Interaction between alpha-Synuclein and SDS Micelles. 223
The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity. 223
Dopamine quinones interact with a-synuclein to form unstructured adducts 220
Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease 218
Antioxidant Therapy in Parkinson's Disease: Insights From Drosophila melanogaster 216
Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? 214
Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment 211
Lifespan and ROS levels in different Drosophila melanogaster strains after 24 h hypoxia exposure 204
The 11-mer repeats of human α−synuclein in vesicle interactions and lipid composition discrimination: a cooperative role. 196
Linking ROS Levels to Autophagy: The Key Role of AMPK 195
Investigation of Streptomyces antibioticus tyrosinase reactivity toward chlorophenols. 191
Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity. 189
DJ-1 and SOD1 Act Independently in the Protection against Anoxia in Drosophila melanogaster 188
Mediterranean Diet and Parkinson’s Disease 185
Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid state. 185
The Reaction of alpha-Synuclein with Tyrosinase - Possible implication for Parkinson disease 184
Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers 180
Structural insights on physiological functions and pathological effects of α-Synuclein 179
Structural characterization of a high affinity mononuclear site in the Copper(II)-alpha-Synuclein complex. 177
Structure and topology of the non-amyloid-beta component fragment of human alpha-synuclein bound to micelles: implications for the aggregation process. 175
The Regulation of MiTF/TFE Transcription Factors Across Model Organisms: from Brain Physiology to Implication for Neurodegeneration 174
Binding Interactions of Agents That Alter α-Synuclein Aggregation. 174
Superoxide Dismutase (SOD)-mimetic M40403 is protective in cell and fly models of paraquat toxicity: Implications for Parkinson disease 174
Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment 173
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease 172
Parkinson's disease and immune system: is the culprit LRRKing in the periphery? 172
Cloning, expression, purification, and spectroscopic analysis of the fragment 57-102 of human alpha-synuclein 168
Metformin repurposing for parkinson disease therapy: Opportunities and challenges 168
Molecular characterization of dopamine-derived quinones reactivitytoward NADH and glutathione: implications for mitochondrial dysfunction inParkinson disease. 167
α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson’s Disease 165
Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant? 163
DJ-1: A promising therapeutic candidate for ischemia-reperfusion injury. 161
Interaction Between alpha-Synuclein and Metal Ions, Still Looking for a Role in the Pathogenesis of Parkinson's Disease 158
Iron Dyshomeostasis in Neurodegeneration with Brain Iron Accumulation (NBIA): Is It the Cause or the Effect? 151
Structures and Interactions of alpha-Synuclein.Physiological and Pathologic al Relevance. 148
Probing the relationship between Gram-negative and Gram-positive S1 proteins by sequence analysis 137
alpha-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells 136
α-Synuclein and Dopamine Metabolites DOPAL and DOPAC: A Pathway to New Synthetic Neuromelanin Models 134
Kinetic and structural analysis of the early oxidation products of dopamine - Analysis of the interactions with alpha-synuclein 131
Metformin repurposing for parkinson disease therapy: Opportunities and challenges 123
Molecular and Physiological Determinants of Amyotrophic Lateral Sclerosis: What the DJ-1 Protein Teaches Us 119
Oxidative Stress and Neuroinflammation in Parkinson's Disease: The Role of Dopamine Oxidation Products 116
Alpha-synuclein interaction with mitochondria is the final mechanism of ferroptotic death induced by erastin in SH-SY5Y cells 110
Exosomal Dynamics and Brain Redox Imbalance: Implications in Alzheimer’s Disease Pathology and Diagnosis 95
Totale 13.155
Categoria #
all - tutte 37.220
article - articoli 36.887
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 333
Totale 74.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 0 0 76
2021/2022802 19 108 107 53 30 41 51 80 23 27 108 155
2022/2023705 117 92 6 117 102 80 0 53 82 13 31 12
2023/2024340 15 36 56 28 26 27 39 9 9 21 39 35
2024/20251.643 9 110 64 53 208 45 134 107 171 68 259 415
2025/20267.157 334 494 852 1.045 655 319 939 588 664 394 632 241
Totale 13.155